13F-HR filed by BVF INC/IL
BVF INC/IL filed this 13F-HR for the quarter ended 2013-06-30, filed 2013-08-14, with 24 holding rows worth $515,282,000.
- Accession
- 0000921895-13-001749
- Filer
- CIK 1056807
- Filed
- 2013-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2013
A holdings report, 24 entries on the cover page, a total value of $515,282,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $515,282,000 with VALUE read as thousands by filing date, 13F file number 028-06800. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerBVF PARTNERS L P/IL028-06770
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LIGAND PHARMACEUTICALS INC | 53220K504 | COM NEW | 3,621,665 | $135,523,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 5,026,766 | $71,078,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 5,252,561 | $52,263,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 11,131,858 | $50,539,000 | thousands by filing date | |
| EXELIXIS INC | 30161QAC8 | NOTE 4.250% 8/1 | 40,735,000 | $39,411,000 | thousands by filing date | principal |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 9,730,697 | $32,501,000 | thousands by filing date | |
| TARGACEPT INC | 87611R306 | COM | 6,171,669 | $26,353,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W100 | CMN | 1,718,905 | $19,888,000 | thousands by filing date | |
| ONCOTHYREON INC | 682324108 | COM | 8,093,278 | $12,626,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC | 04269XAA3 | NOTE 3.000% 6/0 | 12,000,000 | $11,423,000 | thousands by filing date | principal |
| EXELIXIS INC COM | 30161Q104 | Stock | 2,502,256 | $11,360,000 | thousands by filing date | |
| QLT INC | 746927102 | COMMON STOCK | 2,370,263 | $10,405,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 305,786 | $7,513,000 | thousands by filing date | |
| RECEPTOS, INC. | 756207106 | COMMON STOCK | 320,000 | $6,365,000 | thousands by filing date | |
| ARQULE INC | 04269E107 | COM | 2,632,432 | $6,107,000 | thousands by filing date | |
| PAIN THERAPEUTICS INC | 69562K100 | COM | 2,357,327 | $5,210,000 | thousands by filing date | |
| AVANIR PHARMACEUTICALS INC | 05348P401 | CL A NEW | 1,006,053 | $4,628,000 | thousands by filing date | |
| PALATIN TECHNOLOGIES INC | 696077403 | COM PAR $ .01 | 5,200,000 | $3,120,000 | thousands by filing date | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 153,500 | $2,718,000 | thousands by filing date | |
| REGULUS THERAPEUTICS INC | 75915K101 | COM | 266,445 | $2,614,000 | thousands by filing date | |
| ANTHERA PHARMACEUTICALS INC | 03674U102 | COM | 4,477,000 | $2,073,000 | thousands by filing date | |
| FLAMEL TECHNOLOGIES-SP ADR | 338488109 | SPON | 151,406 | $931,000 | thousands by filing date | |
| TRANSCEPT PHARMACEUTICALS IN | 89354M106 | COM | 150,000 | $453,000 | thousands by filing date | |
| GENVEC INC NEW | 37246C307 | cs | 486,100 | $180,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000921895-13-001749 | this filing | 2013-08-14 | acceptance time not in the bulk data set |